[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"adenoid-hypertrophy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:adenoid-hypertrophy":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,52,83,110],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":33,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":51},"100635427","full-wrap-versus-conventional-suspension-for-reducing-soft-palate-injury-rate-100635427",false,"NCT07552545","Full-wrap Versus Conventional Suspension for Reducing Soft Palate Injury Rate","Full-wrap Versus Conventional Suspension for Reducing Soft Palate Injury Rate in Transoral Surgery: A Prospective Randomized Controlled Trial","Inclusion Criteria:\n\n* Voluntarily sign the informed consent form; for patients aged \\\u003C18 years, the informed consent form must be signed by their legal guardian.\n* Age between 2 and 70 years (inclusive), male or female.\n* Patients requiring transoral surgery of the nose, pharynx, parapharyngeal space, or skull base, in which intraoperative soft palate suspension is needed.\n* Intact soft palate mucosa with no ulcers, scars, or other lesions before surgery.\n\nExclusion Criteria:\n\n* Congenital cleft palate or submucous cleft palate.\n* Patients with limited cervical spine mobility, micrognathia, or other conditions affecting surgical exposure.\n* Pregnant or breastfeeding women.\n* Presence of markedly abnormal laboratory test results, such as significant abnormalities in routine blood tests, blood biochemistry, liver and kidney function, or coagulation function.\n* Patients with active infection or infectious diseases.\n* Severe cardiac insufficiency (NYHA class III-IV).\n* Other conditions deemed unsuitable for surgery after evaluation (e.g., concomitant severe heart, brain, or lung diseases; high anesthetic risk; patients not fit for surgery).","ALL","2 Years","70 Years",{"count":20,"type":21},138,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study aims to evaluate whether the use of full-wrap suspension, compared with the traditional double-strap suspension, can effectively reduce the risk of intraoperative and postoperative soft palate injury in transoral\u002Ftransnasal pharyngeal surgery. Through a prospective, multicenter, randomized controlled design, this study will provide evidence-based support for the clinical promotion and standardized application of full-wrap suspension.",[27,28,29,30,31,32],"Adenoid Hypertrophy","Tonsillar Hypertrophy","Nasopharyngeal Diseases","Nasopharyngeal Tumors","Parapharyngeal or Skull Base Lesions","Required Soft Palate Suspension",[34,35,36,37,38],"soft plate injury","Transoral pharyngeal surgery","Soft palate suspension","Randomized controlled trial","Full-wrap suspension","NOT_YET_RECRUITING","2026-05-05",{"date":42,"type":43},"2026-05-08","ACTUAL",{"date":45,"type":21},"2026-04-30",{"date":47,"type":21},"2027-10-31",{"name":49,"class":50},"Sun Yat-sen University","OTHER",1,{"id":53,"slug":54,"hasResults":11,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":4,"eligibilityCriteria":58,"healthyVolunteers":11,"sex":16,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":4,"studyType":63,"phases":4,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":51},"100623623","evaluation-of-the-effects-of-adenoidectomy-and-adenotonsillectomy-on-voice-in-children-100623623","NCT07399041","Evaluation of the Effects of Adenoidectomy and Adenotonsillectomy on Voice in Children","A Prospective Single-Center Study Evaluating the Effects of Adenoidectomy and Adenotonsillectomy on Voice and Speech Functions in Children","Inclusion Criteria:\n\n* Aged 4-13 years\n* Scheduled for primary adenoidectomy or adenotonsillectomy\n\nExclusion Criteria:\n\n* Does not meet inclusion criteria\n* Refuses to participate in the study\n* Diagnosis of vocal cord disorders\n* History of vocal cord surgery\n* History of cleft palate or cleft lip\n* Hearing loss requiring a hearing aid\n* Chronic diseases that may impair wound healing, including: hypertension, diabetes mellitus, immunodeficiency, autoimmune diseases, rheumatologic diseases, connective tissue disorders, renal failure, liver failure, chronic heart disease\n* Known bleeding diathesis\n* Use of anticoagulant or antiplatelet drugs\n* Upper respiratory tract infection within the last 2 weeks\n* Patients undergoing revision adenoidectomy","4 Years","13 Years",{"count":62,"type":21},36,"OBSERVATIONAL","This prospective study aims to evaluate the effects of adenoidectomy and adenotonsillectomy on voice and speech functions in children. Changes in voice quality and resonance may occur after the removal of adenoid and tonsillar tissues, particularly in pediatric patients with enlarged adenoids or tonsils.\n\nObjective voice assessments, including acoustic, aerodynamic, and nasalance measurements, as well as subjective voice-related quality of life questionnaires, will be performed before surgery and at the first and third months after surgery. The results of this study are expected to help clinicians better inform families about possible voice changes following adenoidectomy and adenotonsillectomy procedures.",[27,28,66],"Voice Disorders in Children",[68,69,70,71,72],"Adenoidectomy","Adenotonsillectomy","Pediatric Voice","Nasalance","praat","2026-02-02",{"date":75,"type":43},"2026-02-10",{"date":77,"type":21},"2026-02",{"date":79,"type":21},"2026-08",{"name":81,"class":82},"Gaziosmanpasa Research and Education Hospital","OTHER_GOV",{"id":84,"slug":85,"hasResults":11,"nctId":86,"briefTitle":87,"officialTitle":87,"acronym":4,"eligibilityCriteria":88,"healthyVolunteers":89,"sex":16,"minAge":90,"maxAge":91,"enrollmentInfo":92,"targetDuration":4,"studyType":63,"phases":4,"briefSummary":94,"conditions":95,"keywords":98,"overallStatus":100,"whyStopped":4,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":51},"100600214","evaluation-of-the-effect-of-adenoid-hypertrophy-on-the-masseter-muscle-in-children-a-comparative-ultrasonographic-study-100600214","NCT07094581","Evaluation of the Effect of Adenoid Hypertrophy on the Masseter Muscle in Children: A Comparative Ultrasonographic Study","Inclusion Criteria:\n\n* Children aged between 3 and 8 years\n* Children diagnosed with adenoid hypertrophy\n* Children without any systemic disease\n\nExclusion Criteria:\n\n* Children with a history of surgery for adenoid hypertrophy\n* Children who are uncooperative during clinical examination\n* Children with syndromes involving the maxillofacial region\n* Children with multiple missing teeth",true,"3 Years","8 Years",{"count":93,"type":21},72,"The goal of this observational study is to evaluate the effect of adenoid hypertrophy on the masseter muscle in children aged 3 to 8 years. The primary objectives are:\n\n* To assess whether adenoid hypertrophy affects the thickness or structure of the masseter muscle.\n* To determine whether there is a measurable difference in masseter muscle characteristics between children with and without adenoid hypertrophy.\n\nResearchers will compare children diagnosed with adenoid hypertrophy and scheduled for adenoidectomy to healthy controls without adenoid hypertrophy.\n\nEach participant will:\n\n* Undergo ultrasonographic examination of the masseter muscle using a 9L linear probe (6-15 MHz), and\n* Have their occlusal relationship, dental findings, age, sex, and adenoid hypertrophy grade recorded.",[27,96,97],"Masseter Muscle","Malocclusion",[27,99,96],"Ultrasonography","RECRUITING","2025-12-25",{"date":103,"type":43},"2025-12-29",{"date":105,"type":43},"2024-07-20",{"date":107,"type":21},"2026-02-28",{"name":109,"class":50},"Melis AKYILDIZ",{"id":111,"slug":112,"hasResults":11,"nctId":113,"briefTitle":114,"officialTitle":115,"acronym":4,"eligibilityCriteria":116,"healthyVolunteers":89,"sex":16,"minAge":117,"maxAge":118,"enrollmentInfo":119,"targetDuration":117,"studyType":63,"phases":4,"briefSummary":121,"conditions":122,"keywords":4,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":124,"lastUpdatePostDateStruct":125,"startDateStruct":127,"completionDateStruct":129,"leadSponsor":131,"locationsCount":4},"100567940","it-is-accepted-that-adenoid-hypertrophy-is-related-to-otitis-media-with-effusion-incidence-better-understanding-of-the-correlation-between-the-relative-size-of-ah-and-the-incidence-of-persistent-ome-may-provide-evidence-to-support-a-more-standardized-approach-to-the-diagnosis-and-treatment-of-ome-100567940","NCT06674720","It is Accepted That Adenoid Hypertrophy is Related to Otitis Media With Effusion Incidence. Better Understanding of the Correlation Between the Relative Size of AH and the Incidence of Persistent OME May Provide Evidence to Support a More Standardized Approach to the Diagnosis and Treatment of OME.","Correlation of Site and Size of Adenoid Hypertrophy and Middle Ear Effusion.","Inclusion Criteria:\n\n* Children (until age of 16 years old).\n* Patients with adenoid hypertrophy.\n* Patients with OME.\n\nExclusion Criteria:\n\n* Children known to have cleft palate, submucous cleft palate or other medical problems causing velopharyngeal insufficiency.\n* Down's syndrome, septal deviation, primary ciliary dyskinesia (Kartagener's syndrome), previous head or ear trauma, or previous myringotomy with ventilation tube insertion\n* Systemic medical problems interfering with surgery.\n* Refusal of parents to participate.\n* Craniofacial abnormalities.","1 Year","16 Years",{"count":120,"type":21},60,"The aim of this study is to further investigate the correlation between Site and size of adenoid hypertrophy and middle ear effusion in order to provide evidence for designing a more standardized approach to the diagnosis and treatment of OME.",[27,123],"Middle Ear Effusion","2025-01-16",{"date":126,"type":43},"2025-01-17",{"date":128,"type":21},"2025-05",{"date":130,"type":21},"2027-12",{"name":132,"class":50},"Assiut University"]